Scarica l'app Stockscreener
2.0213
1.22%
-0.0287
Precedente Chiudi:
$2.05
Aprire:
$2.05
Volume 24 ore:
58,763
Relative Volume:
0.08
Capitalizzazione di mercato:
$136.88M
Reddito:
-
Utile/perdita netta:
$-64.20M
Rapporto P/E:
-0.9401
EPS:
-2.15
Flusso di cassa netto:
$57,000
1 W Prestazione:
-3.57%
1M Prestazione:
+2.27%
6M Prestazione:
+59.45%
1 anno Prestazione:
-46.99%
Intervallo 1D:
$2.0101
$2.10
Intervallo di 1 settimana:
$1.95
$2.18
Portata 52W:
$1.05
$4.34
Climb Bio Inc Stock (CLYM) Company Profile
Nome
Climb Bio Inc
Settore
Industria
Telefono
1-866-857-2596
Indirizzo
20 WILLIAM STREET, WELLESLEY HILLS
Confronta CLYM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
2.02 | 138.92M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.02 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.86 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.39 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.90 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.97 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-16 | Iniziato | William Blair | Outperform |
| 2025-10-13 | Iniziato | H.C. Wainwright | Buy |
| 2025-08-15 | Iniziato | Robert W. Baird | Outperform |
| 2025-06-06 | Iniziato | Oppenheimer | Outperform |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Climb Bio Inc Borsa (CLYM) Ultime notizie
Climb Bio to Present at Upcoming Investor Conferences - The Manila Times
Can Climb Bio Inc. stock maintain operating margins2025 Trade Ideas & Real-Time Volume Analysis Alerts - newser.com
Why Climb Bio Inc. stock is recommended by analysts2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Momentum divergence signals in Climb Bio Inc. chartWeekly Risk Report & AI Based Buy and Sell Signals - newser.com
Can momentum traders help lift Climb Bio Inc.Watch List & Momentum Based Trading Ideas - newser.com
Is Climb Bio Inc. stock entering bullish territoryQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsM&A Rumor & Long-Term Safe Return Strategies - newser.com
Predicting Climb Bio Inc. trend using moving averagesQuarterly Earnings Summary & Community Supported Trade Ideas - newser.com
Strategies to average down on Climb Bio Inc.Analyst Downgrade & Reliable Price Action Trade Plans - newser.com
Using R and stats models for Climb Bio Inc. forecastingEarnings Overview Report & Short-Term High Return Ideas - newser.com
Has Climb Bio Inc. formed a bullish divergenceMarket Rally & Risk Managed Investment Strategies - newser.com
What institutional flow reveals about Climb Bio Inc.Weekly Investment Summary & Community Consensus Stock Picks - newser.com
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential - Insider Monkey
10 Best Stocks Under $3 to Invest In - Insider Monkey
Climb Bio, Inc. (NASDAQ:CLYM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Climb Bio’s Promising Phase 1b Study on Budoprutug for Lupus: A Market Game-Changer? - TipRanks
Climb Bio’s Phase 2 Study on Budoprutug: A Potential Game-Changer in Nephrology - TipRanks
Will Climb Bio Inc. stock remain a Wall Street favoriteJuly 2025 Market Mood & Risk Managed Investment Signals - Fundação Cultural do Pará
Climb Bio’s Promising ITP Study: A Potential Game-Changer for Investors - TipRanks
Climb Bio’s Budoprutug Study: A Promising Step Forward - TipRanks
Published on: 2025-10-27 09:11:02 - newser.com
Climb Bio Inc Azioni (CLYM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Climb Bio Inc Azioni (CLYM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
0.68%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):